Carotid Stent Firms See Another Step Into Market With Expanded Coverage
This article was originally published in The Gray Sheet
Executive Summary
Carotid artery stent manufacturers hope to maintain momentum in an evolving market in which they see significant potential for growth
You may also be interested in...
CMS Proposal For Carotid Stenting Coverage Gives A Little, Takes A Little
CMS' proposed revision to its carotid artery stenting Medicare coverage policy is a mixed blessing for manufacturers eager to reach more patients
CMS Proposal For Carotid Stenting Coverage Gives A Little, Takes A Little
CMS' proposed revision to its carotid artery stenting Medicare coverage policy is a mixed blessing for manufacturers eager to reach more patients
ev3’s Protégé Joins Sprouting Field In U.S. Carotid Stent Market
Plymouth, Minn.-based ev3 Inc. joined a growing number of players in the U.S. carotid stent market with the Jan. 25 nationwide launch of its Protégé RX immediately following FDA approval